ICD-11 code : 6C44.71;
Preferred Label : Sedative, hypnotic or anxiolytic-induced anxiety disorder;
ICD-11 definition : Sedative, hypnotic or anxiolytic-induced anxiety disorder is characterized by anxiety
symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic
arousal, avoidance behaviour) that develop during or soon after intoxication with
or withdrawal from sedatives, hypnotics or anxiolytics. The intensity or duration
of the symptoms is substantially in excess of anxiety symptoms that are characteristic
of intoxication or withdrawal due to sedatives, hypnotics or anxiolytics. The amount
and duration of sedative, hypnotic or anxiolytic use must be capable of producing
anxiety symptoms. The symptoms are not better explained by a primary mental disorder
(e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with prominent
anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset
of the sedative, hypnotic or anxiolytic use, if the symptoms persist for a substantial
period of time after cessation of the sedative, hypnotic or anxiolytic use or withdrawal,
or if there is other evidence of a pre-existing primary mental disorder with anxiety
symptoms (e.g., a history of prior episodes not associated with sedative, hypnotic
or anxiolytic use).;
Origin ID : 1506172532;
Automatic exact mappings (from CISMeF team)
Sedative, hypnotic or anxiolytic-induced anxiety disorder is characterized by anxiety
symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic
arousal, avoidance behaviour) that develop during or soon after intoxication with
or withdrawal from sedatives, hypnotics or anxiolytics. The intensity or duration
of the symptoms is substantially in excess of anxiety symptoms that are characteristic
of intoxication or withdrawal due to sedatives, hypnotics or anxiolytics. The amount
and duration of sedative, hypnotic or anxiolytic use must be capable of producing
anxiety symptoms. The symptoms are not better explained by a primary mental disorder
(e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with prominent
anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset
of the sedative, hypnotic or anxiolytic use, if the symptoms persist for a substantial
period of time after cessation of the sedative, hypnotic or anxiolytic use or withdrawal,
or if there is other evidence of a pre-existing primary mental disorder with anxiety
symptoms (e.g., a history of prior episodes not associated with sedative, hypnotic
or anxiolytic use).